Popular Trials
Hormone Therapy
Angiotensin-(1-7) for Cardiovascular Health in Aging
This trial will test whether angiotensin-(1-7), a hormone that protects against the renin-angiotensin system, can reduce the risk of cardiovascular disease in older adults by reducing sympathetic outflow and blood pressure and improving endothelial function.
Neuromodulation
Brain Stimulation for Stress
This trial is testing whether using a non-invasive brain stimulation technique will change how people respond to stress. Healthy participants will do tasks in an MRI machine, then receive brain stimulation in two sessions - one
Behavioural Intervention
Mobile Health Interventions for Cardiovascular Health
This trial will use the mobile health capabilities of smartphones and wearables to assess daily activity measures of the general population and compare these to measures of cardiovascular health risk factors and fitness.
Popular Filters
Trials for Cardiovascular Disease Patients
ASD Occluder
reSept ASD Occluder for Atrial Septal Defect
This trial is testing the safety and effectiveness of the reSept ASD Occluder, a device that closes a specific type of heart hole. It targets patients with secundum atrial septal defect and works by sealing the hole like a patch.
Tissue Engineering
Tissue Engineered Vascular Grafts for Heart Disease
This trial is testing a new type of surgery for people with heart problems. The new surgery is called "extracardiac total cavopulmonary connection." This trial is testing to see if the new surgery is safe and if it works well.
Behavioural Intervention
Pharmacist Intervention for Cardiovascular Disease Prevention
"This trial aims to see if pharmacists can help people reduce their risk of heart disease. Heart disease is a common and serious condition that causes a large number of deaths worldwide. The hope is that by
Behavioral Intervention
Early Mobilization for Cardiovascular Disease
This trial aims to introduce and implement a program that helps cardiac patients move more in the hospital, which has been shown to improve their health and increase the chance of going home sooner. The study will focus
Trials for CVD Patients
ASD Occluder
reSept ASD Occluder for Atrial Septal Defect
This trial is testing the safety and effectiveness of the reSept ASD Occluder, a device that closes a specific type of heart hole. It targets patients with secundum atrial septal defect and works by sealing the hole like a patch.
Tissue Engineering
Tissue Engineered Vascular Grafts for Heart Disease
This trial is testing a new type of surgery for people with heart problems. The new surgery is called "extracardiac total cavopulmonary connection." This trial is testing to see if the new surgery is safe and if it works well.
Behavioural Intervention
Pharmacist Intervention for Cardiovascular Disease Prevention
"This trial aims to see if pharmacists can help people reduce their risk of heart disease. Heart disease is a common and serious condition that causes a large number of deaths worldwide. The hope is that by
Behavioral Intervention
Early Mobilization for Cardiovascular Disease
This trial aims to introduce and implement a program that helps cardiac patients move more in the hospital, which has been shown to improve their health and increase the chance of going home sooner. The study will focus
Phase 3 Trials
RNA-based Therapeutic
Inclisiran for Cardiovascular Disease
This trial tests inclisiran, a new injection to lower cholesterol, in people who have had heart attacks, strokes, or surgeries for blocked arteries. It works by blocking a protein that produces bad cholesterol.
Trials With No Placebo
Behavioral Intervention
Telenutrition for Obesity in Spinal Cord Injury
This trial will provide nutrition counseling to obese people with spinal cord injuries via FaceTime, in order to improve their eating habits and heart health. There will be 3 in-person visits required, spaced 3 months apart, for a total trial length of 6 months.
ASD Occluder
reSept ASD Occluder for Atrial Septal Defect
This trial is testing the safety and effectiveness of the reSept ASD Occluder, a device that closes a specific type of heart hole. It targets patients with secundum atrial septal defect and works by sealing the hole like a patch.
Tissue Engineering
Tissue Engineered Vascular Grafts for Heart Disease
This trial is testing a new type of surgery for people with heart problems. The new surgery is called "extracardiac total cavopulmonary connection." This trial is testing to see if the new surgery is safe and if it works well.
View More Related Trials
Frequently Asked Questions
Introduction to cardiovascular
What are the top hospitals conducting cardiovascular research?
Cutting-edge cardiovascular research is taking place at top hospitals across the United States, paving the way for improved treatments and outcomes for patients with heart conditions. One notable institution leading the charge is the National Institutes of Health Clinical Center in Bethesda. While they currently have four active cardiovascular trials underway, their commitment to advancing cardiac medicine extends beyond specific numbers; it lies in their esteemed reputation as a premier research facility. Similarly, the University of Kansas Medical Center in Kansas City has three ongoing cardiovascular trials that demonstrate their dedication to exploring innovative approaches to heart health.
In Charlottesville, Virginia, the University of Virginia focuses its efforts on cardiovascular research with three active trials and an impressive history of one previously conducted trial dating back to 2021. This young but promising track record demonstrates their commitment to advancing knowledge and treatment options for individuals affected by heart disease.
Meanwhile, Vanderbilt University in Nashville has also emerged as a leader in cardiovascular clinical trials with three ongoing studies aimed at addressing various aspects of cardiac health. Rounding out this list is Excel Medical Clinical Trials located in Boca Raton—a dynamic center contributing significantly through its involvement in three current cardiovascular trials.
These hospitals represent a collective force that strives towards enhancing our understanding of cardiovascular diseases while continually pushing boundaries within medical science and patient care. Their relentless pursuit not only promises new therapeutic breakthroughs but also brings hope to millions around the country living with or impacted by heart-related conditions. Together, these institutions exemplify how collaboration between dedicated researchers and cutting-edge facilities can shape a healthier future for all individuals battling against cardiac ailments
Which are the best cities for cardiovascular clinical trials?
When it comes to cardiovascular clinical trials, several cities emerge as leading hubs for research and development. Boston, Massachusetts is at the forefront with 11 active trials investigating treatments like Olpasiran, reSept ASD Occluder, and Inclisiran. New york, New York follows closely behind with 9 ongoing studies exploring interventions such as Red Blood Cell therapy and BLB Intervention alongside other potential breakthroughs. Las Vegas, Nevada also shows promise with 9 active trials focused on investigational drugs like Orforglipron and Olezarsen. Lastly, Aurora, Colorado and Jacksonville, Florida both exhibit strong involvement in cardiovascular clinical trials with 8 active studies each targeting various treatments for conditions including ASCVD. These cities offer individuals seeking innovative approaches to cardiovascular care access to cutting-edge clinical research that paves the way for advancements in treatment options and potentially improved outcomes.
Which are the top treatments for cardiovascular being explored in clinical trials?
Clinical trials exploring potential treatments for cardiovascular conditions are currently centered around one promising approach: one bout of moderate-intensity sub-maximal aerobic exercise. This innovative method is being tested in a single active trial, which marks the only cardiovascular trial thus far. Its initial listing in 2022 indicates its recent emergence as a frontrunner among researchers seeking novel ways to address cardiovascular health concerns. As scientists delve further into this avenue of exploration, they hope to uncover new insights and possibilities for patients worldwide.
What are the most recent clinical trials for cardiovascular?
Recent clinical trials in the field of cardiovascular research have uncovered promising developments. One notable study focuses on moderate intensity, continuous training (MICT) as a potential intervention for patients with cardiovascular conditions. Another trial examines the efficacy of Orforglipron in treating these ailments, while a separate investigation explores the use of melatonin for cardiovascular health. Additionally, researchers are studying Olpasiran and LY3473329 Dose 1 to assess their impact on people suffering from cardiovascular issues. These innovative trials shed light on potential breakthroughs that could lead to improved treatments and outcomes for individuals with cardiovascular conditions.
What cardiovascular clinical trials were recently completed?
Several significant cardiovascular clinical trials have recently concluded, bringing us closer to advancements in the field of cardiac health. One such trial was completed by Johns Hopkins University in November 2021, exploring a new therapy's effectiveness in reducing heart failure risks. In September 2021, the National Heart, Lung, and Blood Institute wrapped up their trial investigating a novel medication for treating high blood pressure. Additionally, Emory University successfully concluded a trial in January 2021 that examined the impact of lifestyle interventions on preventing heart disease. These groundbreaking studies contribute invaluable insights into cardiovascular care and pave the way for improved treatments and prevention strategies.